Insider trades
Daniel S. Lorrain, Chief Officer of Contineum Therapeutics CTNM, has filed 0 purchases and 17 sales on the open market. Over the past 12 months that comes to a net sale of $523.2K. The latest trade was on 06/01.
Daniel S. Lorrain
Chief Scientific Officer
- Company
- Contineum Therapeutics CTNM
- First filing
- 24/05/29
- Trades
- 31 trades
- Buys / sales
- 0 / 17
- 12-month net buying
- −$523.2K
- Last trade
- 06/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/01 | 06/01 | 4,170 sh | $13.16 | $54,877.2 | −2.9% | |
CTNM | Open-market sale10b5-1 plan | 05/01 | 05/01 | 4,170 sh2 trades | $13.12avg. | $54,694.2 | −2.8% |
| Open-market sale10b5-1 plan | 04/06 | 04/06 | 4,170 sh | $13.43 | $56,003.1 | −2.7% | |
| Open-market sale10b5-1 plan | 03/02 | 03/02 | 4,170 sh | $15.01 | $62,591.7 | −2.7% | |
CTNM | Open-market sale10b5-1 plan | 02/24–02/25 | 02/26 | 8,124 sh2 trades | $16.02avg. | $130,151.24 | −4.9% |
| Open-market sale10b5-1 plan | 02/19 | 02/20 | 100 sh | $16.00 | $1,600 | −0.1% | |
| Open-market sale10b5-1 plan | 02/11 | 02/13 | 400 sh | $16.00 | $6,400 | −0.3% | |
CTNM | Open-market sale10b5-1 plan | 02/03 | 02/05 | 4,170 sh2 trades | $14.94avg. | $62,302.5 | −2.6% |
CTNM | Open-market sale10b5-1 plan | 01/05 | 01/06 | 4,170 sh2 trades | $10.44avg. | $43,549.5 | −2.5% |
| Open-market sale10b5-1 plan | 25/12/23 | 25/12/30 | 4,170 sh | $12.23 | $50,999.1 | −2.5% | |
| Open-market sale10b5-1 plan | 24/11/25 | 24/11/27 | 1,010 sh | $16.02 | $16,180.2 | −0.6% | |
CTNM | Open-market sale10b5-1 plan | 24/11/18 | 24/11/20 | 6,190 sh2 trades | $16.38avg. | $101,397.62 | −3.5% |